1404-1405 / 2953
Rousseau
Cancer
Radioth 2012
10 pts
PTV 723 (392-
885 cc)
V5: 13% higher VMAT
V20: 24 vs 20 (p<0.01)
V30: 20 vs 14 (p<0.01)
MLD 14 vs 12.2 Gy
Cattaneo
Radiot Oncol
2008
13 pts
PTV: 215-745
Dmean: 20.4 vs 16.8 Gy
p=0.001
V5: 67.4 vs 70.4% p= 0.61
V10: 56.4 vs 54.2% p=0.694
3D vs. IMRT: lung DVHs
V15: 43.1 vs 37.4% p=0.013
V20: 33.5 vs 25.8% p= 0.002
V30: 27 vs 17.5% p=0.001
Scrimger
AMJCO 2003
5 pts
PTV 169cc (132-
280)
TOMO:
Mean lung dose reduction of 31% (10-53%)
Mean V20 reduction of 22% (17-37%)